 Several studies suggest that the infused T cells need room to be able to proliferate and accomplish their functions and that this may not happen if there are too many other T cells in circulation. Because of that, if the patients level of circulating T cells is relatively high, she may require treatment with cyclophosphamide Cytoxan and fludarabine before she receives MABEL CTLs. 